NEVO™: A new generation of sirolimus-eluting coronary stent

EuroIntervention

Volumn 5, Issue SUPPL. F, 2009, Pages

  Falotico, Robert ^a,b   Parker, Theodore ^a,b   Grishaber, Randy ^a,b   Price, Sylvester ^a,b   Cohen, Sidney A ^a,b   Rogers, Campbell ^a,b  

^a JOHNSON AND JOHNSON   (United States)

^b Johnson and Johnson Company   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM; COBALT; ETHYLENE VINYL ACETATE COPOLYMER; EVEROLIMUS; PACLITAXEL; POLY N BUTYL METHACRYLATE; POLYGLACTIN; POLYMER; RAPAMYCIN; STAINLESS STEEL; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; BIODEGRADABILITY; CORONARY ARTERY DISEASE; CORONARY STENT; DIABETES MELLITUS; DRUG DELIVERY SYSTEM; DRUG ELUTING STENT; EQUIPMENT DESIGN; HUMAN; MATERIAL COATING; MECHANICAL STRESS; MEDICAL RESEARCH; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STENT THROMBOSIS; TREATMENT OUTCOME; VISCOSITY;

EID: 77954110470     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/eijv5ifa15     Document Type: Review

References (13)

1. Morice M-C, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi, G, Molnàr, F, Falotico, R for the RAVEL Study Group. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-1780. (Pubitemid 34586912)
2. Weisz G, Leon MB, Holmes DR, Kereiakes DJ, Popma, JJ, Teirstein PS, Cohen SA, Wang H, Cutlip DE, Moses JW. Five-Year Follow-Up After Sirolimus-Eluting Stent Implantation: Results of the SIRIUS Trial. J Amer Coll Cardiol 2009;53:1488-1497.
3. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Tift Mann J, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell MJ, for the TAXUS-IV Investigators. One-Year Clinical Results with the Slow- Release, Polymer-Based, Paclitaxel-Eluting TAXUS Stent, The TAXUS-IV Trial. Circulation 2004;109:1942-1947. (Pubitemid 38544483)
4. Kandzari DE, Leon MB, Popma JJ, Fitzgerald PJ, O'Shaughnessy C, Ball MW, Turco M, Applegate RJ, Gurbel PA, Midei MG, Badre SS, Mauri L, Thompson KP, LeNarz LA, Kuntz RE, for the ENDEAVOR III Investigators. Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients with Native Coronary Artery Disease, A Randomized Controlled Trial. J Amer Coll Cardiol. 2006;48:2440-2447. (Pubitemid 44881222)
5. Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, Farhat N, Caputo R, Xenopoulos N, Applegate R, Gordon P, White RM, Sudhir K, Cutlip DE, Petersen JL; SPIRIT III Investigators. Randomized Comparison of Everolimus-Eluting and Paclitaxel-Eluting stents: Two-year Clinical Follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial. Circulation 2009;119:680-6.
6. Jeong B, Bae YH, Lee DS, Kim, SW. Biodegradable Block Copolymers as Injectable Drug-delivery Systems, Nature 1997;388:860-862. (Pubitemid 27377054)
7. Wu XS, Wang N. Synthesis, Characterization, Biodegradation and Drug Delivery Application of Biodegradable Lactic/glycolic Acid Polymers. Part II: Biodegradation, J. Biomaterial Sci. Polymer Ed., 2001;12:21-34.
8. Spaulding C. Six Month Results of the RES-ELUTION I (RES-I) Trial. Late Breaking Clinical Trials Presentation, EuroPCR 2009.
9. van Werkum JW, Heestermans AA, Zomer AC, Kelder JC, Suttorp MJ, Rensing BJ, Koolen JJ, Brueren BR, Dambrink JH, Hautvast RW, Verheugt FW, ten Berg JM. Predictors of Coronary Stent Thrombosis: the Dutch Stent Thrombosis Registry. J Am Coll Cardiol. 2009;53:1399-409.
10. Cook S, Ladich E, Nakazawa G, Eshtehardi P, Neidhart M, Vogel R, Togni M, Wenaweser P, Billinger M, Seiler C, Gay S, Meier B, Pichler WJ, Jüni P, Virmani R, Windecker S. Correlation of Intravascular Ultrasound Findings With Histopathological Analysis of Thrombus Aspirates in Patients With Very Late Drug-Eluting Stent Thrombosis. Circulation 2009;120:391-399.
11. Yellon DM, Hausenloy DJ. Myocardial Reperfusion Injury. N Engl J Med. 2007;357:1121-35.
12. Lee TT, Feinberg L, Baim DS, Holmes DR, Aroesty JM, Carrozza JP Jr, Cohen DJ, Ho KK, Cutlip DE. Effect of Diabetes Mellitus on Five-Year Clinical Outcomes After Single-Vessel Coronary Stenting (Pooled Analysis of Coronary Stent Clinical Trials). Am J Cardiol. 2006;98:718-21. (Pubitemid 44301000)
13. Stettler C, Allemann S, Wandel S, Kastrati A, Morice MC, Schömig A, Pfisterer ME, Stone GW, Leon MB, de Lezo JS, Goy JJ, Park SJ, Sabaté M, Suttorp MJ, Kelbaek H, Spaulding C, Menichelli M, Vermeersch P, Dirksen MT, Cervinka P, De Carlo M, Erglis A, Chechi T, Ortolani P, Schalij MJ, Diem P, Meier B, Windecker S, Jüni P. Drug Eluting and Bare Metal Stents in People with and Without Diabetes: Collaborative Network Meta-Analysis. BMJ. 2008;337:1331-42.